This session will examine the unique features of epilepsy in older adults, with a focus on new-onset unprovoked seizures (late-onset epilepsy) and the evaluation and management of cognitive impairment in patients with longstanding epilepsy. Faculty will discuss the relationship between epilepsy and Alzheimer’s disease, including the role of biomarker testing, neuropsychological assessment, and potential implications […] Read More
Rapid technological advances are transforming neurological care, but without intentional implementation and equity-focused frameworks, these innovations risk exacerbating global disparities. Emerging tools—including AI-assisted diagnostics, portable low-field MRI, dry-electrode EEG, and gene-based therapies—offer significant potential to expand access in resource-limited settings. The challenge lies in deploying these technologies ethically, sustainably, and inclusively. This session will bring […] Read More
The fields of multiple sclerosis (MS) and autoimmune neurology are rapidly evolving, with an expanding therapeutic landscape and increasing opportunities for precision treatment. In MS, B cell–targeted therapies have transformed disease management, offering high efficacy in reducing disease activity and preventing relapses. However, long-term immunosuppression raises important safety and cost considerations, and emerging evidence suggests […] Read More